Pharmaceuticals

Travel Vaccines Market Outlook 2026–2035: Growth Drivers and Industry Forecast

February 27, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the travel vaccines market from 2026–2035 with trusted insights from The Business Research Company

What level of CAGR-driven expansion is anticipated in the Travel Vaccines Market between 2026 and 2030?

The travel vaccines market has experienced robust expansion over recent years. Projections indicate its expansion from $5.09 billion in 2025 to $5.56 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.2%. Historically, this growth can be ascribed to factors such as restricted vaccine availability in emerging markets, low public understanding of travel-related illnesses, a reliance on conventional vaccination centers, regulatory clearances for mono vaccines, and a gradual adoption of online booking platforms.

The travel vaccines market is projected to experience substantial expansion over the coming years. By 2030, this market is anticipated to reach $8.16 billion, demonstrating a compound annual growth rate (CAGR) of 10.0%. This projected growth is driven by several factors, including a surge in global travel and mobility, innovations in biotechnology for combination vaccines, the expansion of digital health and telemedicine services, heightened awareness of preventive healthcare, and the broadening of international travel immunization programs. Key trends anticipated during this period encompass a rise in international tourism and business travel, greater awareness among travelers regarding preventive healthcare, the proliferation of online travel health services and booking platforms, the development of combination and multivalent travel vaccines, and an increase in public-private partnerships for global immunization programs.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11918&type=smp

What Drivers Are Affecting Demand-Supply Dynamics In The Travel Vaccines Market?

The anticipated expansion of travel and tourism is projected to propel the growth of the travel vaccine market in the forthcoming period. Travel and tourism refers to the movement of individuals or items, encompassing vehicles such as trains, boats, airplanes, and other conveyances, between various distant geographic areas. Travel vaccines prove beneficial for tourists and travelers by helping maintain their safety and health during international journeys. For instance, in May 2025, according to UN Tourism, a Spain-based specialized agency responsible for the promotion of responsible, sustainable, and universally accessible tourism, over 300 million tourists undertook international travel in the first three months of 2025, approximately 14 million more than during the same period in 2024, which marked a 5% year-on-year increase. Thus, the escalation in travel and tourism is fostering the growth of the travel vaccine market.

How Is The Travel Vaccines Market Organized Into Various Segments?

The travel vaccines market covered in this report is segmented –

1) By Disease: Hepatitis A, Diphtheria, Pertussis, And Tetanus (DPT), Yellow Fever, Typhoid, Hepatitis B, Measles And Mumps, Rabies, Meningococcal, Other Diseases,

2) By Composition: Mono Vaccines, Combination Vaccines

3) By Booking Channel: Online Booking, In-Person Booking

4) By Application: Domestic Travel, Outbound Travel

Which Competitive Trends Are Impacting The Structure Of The Travel Vaccines Market?

Leading firms within the travel vaccine sector are creating advanced vaccines that offer active immunity to ward off Hepatitis A, a frequent worry for those journeying. A travel vaccine serves as a specialized immunization crafted to shield people from contagious illnesses common in specific geographic locations or nations, frequently suggested for travelers heading to such destinations. As an illustration, in January 2024, Indian Immunologicals Ltd. (IIL), an India-based biotechnology enterprise, introduced Havisure, which stands as India’s first domestically developed Hepatitis A vaccine. Havisure is expected to play a crucial role in safeguarding against the Hepatitis A virus, primarily affecting the liver. This vaccine effectively prevents the illness and is recommended for children as part of their standard immunization schedule. Furthermore, it is suggested for individuals prone to exposure or those venturing to regions with elevated occurrences of Hepatitis A.

Who Are The Top-Performing Companies In The Travel Vaccines Market In Recent Years?

Major companies operating in the travel vaccines market are Pfizer Inc, Johnson and Johnson, Merck & Co. Inc, Sanofi SA, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Serum Institute of India Pvt. Ltd., Bavarian Nordic A/S, Valneva SE, Panacea Biotec, Bharat Biotech International Limited, Bio Farma, Novavax Inc, Emergent BioSolutions UK, Biological E. Limited, Vabiotech, Cadila Healthcare Limited, Zydus Lifesciences Ltd, Cipla Inc, Haffkine Biopharmaceutical Corporation Ltd

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/travel-vaccines-global-market-report

Which Region Currently Holds The Largest Share Of The Travel Vaccines Market?

North America was the largest region in the travel vaccines market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the travel vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Travel Vaccines Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=11918&type=smp

Browse Through More Reports Similar to the Global Travel Vaccines Market 2026, By The Business Research Company

Travel Vaccines Market Report 2026

https://www.thebusinessresearchcompany.com/report/travel-vaccines-global-market-report

Vaccines Market Report 2026

https://www.thebusinessresearchcompany.com/report/vaccines-global-market-report

Vaccine Delivery Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/vaccine-delivery-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795